Bicara Therapeutics Inc. Common Stock
BCAX | NASDAQ
$22.46
+$0.45 (+2.04%)
Sep 22, 2026, 12:11 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -185.36M | -157.32M | -137.95M | -121.52M | -102.67M | -92.33M | -68M | -59.48M | -64.84M | -56.14M | -51.99M | -39.55M | -16.7M | -8.35M |
Depreciation & Amortization | 424K | 399K | 374K | 77K | 68K | 62K | 56K | 55K | 42K | 30.5K | 19K | 5K | 3K | 1.5K |
Stock-Based Compensation | 22.16M | 17.41M | 15.01M | 13.74M | 12.16M | 9.7M | 7.4M | 4.98M | 3.47M | 2.74M | 1.9M | 1.13M | 615K | 307.5K |
Other Working Capital | 10.95M | 2.2M | 4.35M | -12.48M | -12.04M | -12.5M | -19.77M | -548K | -1.93M | -2.36M | 502K | -2.44M | -880K | -440K |
Other Non-Cash Items | -10.02M | 1.4M | 927K | 354K | 141K | -4K | -77K | 880K | 14.17M | 9.05M | 3.94M | 3.26M | -10.1M | -5.05M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 37.95M | 21.87M | 14.81M | -5.63M | -10.65M | -5.7M | -14.13M | 807K | 1.1M | -2.36M | 502K | -2.44M | -880K | -440K |
Operating Cash Flow | -134.85M | -116.24M | -106.83M | -112.98M | -100.96M | -88.27M | -74.75M | -52.76M | -46.06M | -46.69M | -45.63M | -37.59M | -27.06M | -13.53M |
Capital Expenditures | -400K | -340K | -280K | -82K | -48K | -67K | -71K | -467K | -609K | -590K | -586K | -150K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -563.1M | -318.17M | -318.17M | -236.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 161M | 101M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 62K | 62K | 62K | 62K | n/a | n/a | n/a | n/a |
Investing Cash Flow | -402.5M | -217.51M | -318.45M | -236.16M | -48K | -67K | -9K | -405K | -547K | -528K | -586K | -150K | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 77K | 77K | 77K | 214K | 137K | 221K | 19.17M | 37.98M | 37.98M | 37.89M | 18.95M |
Financial Cash Flow | 197.34M | 195.15M | 32.26M | 56K | 333.76M | 334.35M | 334.03M | 529.71M | 235.48M | 253.69M | 272.5M | 77.79M | 37.89M | 18.95M |
Net Cash Flow | -340.01M | -138.6M | -393.03M | -349.09M | 232.75M | 462.07M | 475.32M | 692.6M | 404.91M | 216.05M | 230.44M | 44.21M | 14.99M | n/a |
Free Cash Flow | -135.25M | -116.58M | -107.11M | -113.06M | -101M | -88.34M | -74.82M | -53.22M | -46.67M | -47.28M | -46.21M | -37.74M | -27.06M | -13.53M |
Adj. Free Cash Flow | -157.41M | -133.99M | -122.12M | -126.8M | -113.16M | -98.04M | -82.22M | -58.2M | -50.14M | -50.01M | -48.11M | -38.88M | -27.68M | -13.84M |
Maintenance CapEx | -350K | -306K | -262K | -39K | -23K | -36K | -40K | -39K | -33K | -20K | -16K | n/a | n/a | n/a |
Growth CapEx | -50K | -34K | -18K | -43K | -25K | -31K | -31K | -428K | -576K | -570K | -570K | n/a | n/a | n/a |
Owner Earnings | -135.2M | -116.54M | -107.1M | -113.02M | -100.98M | -88.31M | -74.79M | -52.79M | -46.1M | -46.71M | -45.64M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BCAX